Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 
QUINUPRISTIN

How to Advertise on Betterchem.com…

    Most advertising on this site is managed by Google Adwords. Adwords lets businesses advertise on sites regardless of their budget. At Betterchem, your Ad campaigns can target keywords and/or the visitor's geographical location. We do not participate in Adwords targeted campaigns at this time.

   

If you would like to target one or more of our network's 200,000 plus pages…

    Purchase a banner space for a low monthly fee. Banner spaces on individual pages are available for as little as $50/month. Email sales@betterchem.com. Place "Banner Placement" in the subject line and include our page's URL (where you'd like your banner to appear) in the subject. You need to supply us with links to your banner image and URL for the target page (at your site). We will revert with price and conditions. Betterchem reserves the right to refuse ads that do not meet our editorial standards.

 

 
Free Ad space for your pharma products.

Simply list your products and create a reciprocal link. See how.

 

 


Ad page index… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Keywords for the Ads: SYNERCID I.V. (quinupristin and dalfopristin for injection), Aventis Products NDA 50-747/S-002 3/13/02 3/29/02 SYNERCID I.V. (quinupristin and dalfopristin for injection), Rhone Poulenc Rorer NDA 50-747 and NDA 50-748 9/21/99 10/6/99 &10/6/99 9/24/99 & 9/24/99 7/18/01 SYNERCID I.V. Indications: for the treatment of patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium (VREF) bacteremia (Subpart H; NDA 50-747) and Complicated Skin and Skin Structure infections caused by Staphylococcus aureus (methicillin susceptible) or Streptococcus pyogenes (NDA 50-748). DALFOPRISTIN; QUINUPRISTIN Iv (Infusion) 350MG/VIAL;150MG/VIAL SYNERCID KING

© 2008 Betterchem Corp.